Bafna Pharmaceuticals (BAFNAPH) Share Price near 52-week high as stock trades at Rs 477.90
- September 24, 2026
- Posted by: Chaitanya Auti
- Category: News
Bafna Pharmaceuticals Share Price is Rs 477.90, up 1.97%, and trading near its 52-week high. The company’s market cap stands at Rs 1,130.54 crore, placing Bafna Pharmaceuticals Share Price in market focus today.
Bafna Pharmaceuticals Share Price is at Rs 477.90, up Rs 9.25 from the previous close of Rs 468.65, and the move keeps Bafna Pharmaceuticals Ltd. (BAFNAPH) close to its 52-week high. The stock opened at Rs 469.80 and traded between Rs 469.80 and Rs 477.90 as of 21 October 2026 at 9:22 AM IST. With a market capitalisation of Rs 1,130.54 crore, Bafna Pharmaceuticals Share Price remains a notable item in Bafna Pharmaceuticals Stock News and Bafna Pharmaceuticals Share Price Today searches.
Bafna Pharmaceuticals Share Price Today: Price Action Analysis
According to latest Univest data, the near 52-week high event is relevant because the share price is already within 2% of that level. The latest market snapshot confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Bafna Pharmaceuticals Share Price, the main takeaway is that the stock is trading close to its yearly high while the business metrics and sector benchmarks provide the broader context. Bafna Pharmaceuticals Share Price has therefore become part of the day’s Indian stock market conversation without requiring a fresh corporate announcement.
| Metric | Value |
|---|---|
| Current Price | Rs 477.9 |
| Previous Close | Rs 468.65 |
| Today's Move | +Rs 9.25 (+1.97%) |
| Open | Rs 469.8 |
| High | Rs 477.9 |
| Low | Rs 469.8 |
| Market Capitalisation | Rs 1,130.54 crore |
Bafna Pharmaceuticals Ltd. (BAFNAPH) traded at Rs 477.9 versus the previous close of Rs 468.65, a rise of 1.97%. The stock opened at Rs 469.8, reached a high of Rs 477.9 and touched a low of Rs 469.8.
Bafna Pharmaceuticals Share Price Today shows a clear intraday move from the previous close to the current level. The stock began the morning at Rs 469.80, matched the day’s low at the same level, and then moved up to Rs 477.90, which is also the day’s high. The day change of Rs 9.25 translates into 1.97%, keeping Bafna Pharmaceuticals Share Price close to the 52-week high and within the event zone that attracts market updates and stock news coverage.
What exactly happened today is straightforward: Bafna Pharmaceuticals Share Price traded above the previous close and held near the upper end of the day’s range. That makes the move relevant for readers following Bafna Pharmaceuticals Share Price Live, Bafna Pharmaceuticals Share Price Update and Bafna Pharmaceuticals Latest News. The latest price action does not need a separate explanation beyond the verified numbers. In a stock market today context, the move simply places Bafna Pharmaceuticals Share Price among stocks in news that are trading near a one-year high.
Bafna Pharmaceuticals Ltd. (BAFNAPH) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,130.54 crore |
| P/E Ratio | 145.16x |
| P/B Ratio | 11.75x |
| ROE | 12.27% |
| ROCE | 11.87% |
| EPS | Rs 3.29 |
| Book Value Per Share | Rs 40.68 |
| Dividend Yield | 0% |
Bafna Pharmaceuticals Ltd. (BAFNAPH) fundamental metrics show P/E 145.16x, P/B 11.75x, ROE 12.27%, ROCE 11.87%. These figures provide context only and are not a buy or sell signal.
Bafna Pharmaceuticals Ltd. has a market capitalisation of Rs 1,130.54 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 145.16x, P/B at 11.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.27% and ROCE of 11.87%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.29, book value per share of Rs 40.68, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.67x, median ROE of 11.23%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 145.16x |
| Benchmark Median P/E | 26.67x |
| Benchmark Average P/E | 38.75x |
| Benchmark P/E Range | 0x to 616.89x |
| Company P/B Ratio | 11.75x |
| Benchmark Median P/B | 2.74x |
| Company ROE | 12.27% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 11.87% |
| Benchmark Median ROCE | 13.25% |
| Company Market Capitalisation | Rs 1,130.54 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Bafna Pharmaceuticals Ltd. (BAFNAPH) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bafna Pharmaceuticals Ltd. (BAFNAPH) has a P/E ratio of 145.16x, which is above the benchmark median of 26.67x, a difference of +444.28%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Bafna Pharmaceuticals Ltd. (BAFNAPH) has a ROE of 12.27%, which is above the benchmark median of 11.23%, a difference of +9.26%. Bafna Pharmaceuticals Ltd. (BAFNAPH) has a ROCE of 11.87%, which is below the benchmark median of 13.25%, a difference of -10.42%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Bajaj Healthcare Ltd. | BAJAJHCARE | 1,142.6 | 45.78 | 2.05 | 4.35 | 7.04 |
| Bharat Parenterals Ltd. | BPLPHARMA | 1,191.55 | 0 | 3.74 | -8.36 | -1.82 |
| Lincoln Pharmaceuticals Ltd. | LINCOLN | 1,067.18 | 11.06 | 1.34 | 12.3 | 16.27 |
| Sigachi Industries Ltd. | SIGACHI | 1,019.87 | 40.23 | 1.92 | -14.75 | -10.72 |
| Kopran Ltd. | KOPRAN | 1,350.96 | 54.07 | 2.52 | 4.92 | 6.65 |
Bafna Pharmaceuticals Ltd. (BAFNAPH) has a P/E ratio of 145.16x compared with the displayed peer median of 40.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.27% compares with a peer median of 4.35% across the companies shown in the table. ROCE stood at 11.87% versus the displayed peer median of 6.65%, providing a capital-efficiency comparison. Bafna Pharmaceuticals Ltd. (BAFNAPH) has a market capitalisation of Rs 1,130.54 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Bafna Pharmaceuticals
- Bafna Pharmaceuticals Share Price is Rs 477.90, up 1.97% from the previous close of Rs 468.65.
- Bafna Pharmaceuticals Share Price is trading near its 52-week high and within the near-high event zone tracked by Univest.
- The company’s P/E ratio is 145.16 and its P/B ratio is 11.75.
- ROE is 12.27% and ROCE is 11.87%, giving Bafna Pharmaceuticals Share Price a measurable profitability context.
- In the same industry benchmark, Bafna Pharmaceuticals Share Price sits above the median P/E and P/B levels.
About Bafna Pharmaceuticals
Bafna Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Bafna Pharmaceuticals Share Price is therefore linked to a company whose latest visible market profile includes a market capitalisation of Rs 1,130.54 crore, an EPS of 3.29, a book value of Rs 40.68 per share and a dividend yield of 0. The latest quarter revenue figure available in the market snapshot is Rs 26.58 crore for Jun 2026. Readers following Bafna Pharmaceuticals Share Price, Bafna Pharmaceuticals Company News and Bafna Pharmaceuticals Stock News can use these numbers as the core company profile reference.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What is Bafna Pharmaceuticals Share Price today?
Ans. Bafna Pharmaceuticals Share Price is Rs 477.90 as of 21 October 2026 at 9:22 AM IST. It is up 1.97% from the previous close of Rs 468.65 and remains near its 52-week high.
How much did Bafna Pharmaceuticals Share Price move today?
Ans. Bafna Pharmaceuticals Share Price moved up by Rs 9.25 today. The current level of Rs 477.90 compares with a previous close of Rs 468.65, showing a 1.97% change in early trade.
Why is Bafna Pharmaceuticals Share Price in focus?
Ans. Bafna Pharmaceuticals Share Price is in focus because it is trading near its 52-week high. The company also has a market capitalisation of Rs 1,130.54 crore, which keeps it visible in market scans.
What does the valuation of Bafna Pharmaceuticals Share Price show?
Ans. Bafna Pharmaceuticals Share Price carries a P/E of 145.16 and a P/B of 11.75. Those numbers are higher than the industry median levels, so valuation remains a key part of the discussion.
What are the key profitability numbers for Bafna Pharmaceuticals?
Ans. Bafna Pharmaceuticals reports ROE of 12.27% and ROCE of 11.87%. EPS is 3.29 and book value is Rs 40.68 per share, which helps place Bafna Pharmaceuticals Share Price in a financial context.
How does Bafna Pharmaceuticals compare with industry benchmarks?
Ans. Bafna Pharmaceuticals Share Price is above the industry median P/E of 26.67 and P/B of 2.74. Its ROE is above the benchmark median, while ROCE is below the benchmark median for the same industry.
What is the market cap of Bafna Pharmaceuticals?
Ans. Bafna Pharmaceuticals Share Price is linked to a market capitalisation of Rs 1,130.54 crore. That places the company above the industry median market cap of Rs 768.75 crore in the same industry benchmark.
What should readers monitor in Bafna Pharmaceuticals Stock News?
Ans. Readers tracking Bafna Pharmaceuticals Stock News should monitor the share price near the 52-week high, the valuation ratios, revenue for Jun 2026 and the company’s position versus peers in Pharmaceuticals & Drugs.
Track Bafna Pharmaceuticals Share Price on Univest
Use Bafna Pharmaceuticals Ltd. (BAFNAPH) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Bafna Pharmaceuticals Share Price on Univest for live price updates, ratio snapshots, 52-week levels, market cap, peer context and company-specific market insights. Bafna Pharmaceuticals Share Price Today can be followed alongside Bafna Pharmaceuticals Share News and Bafna Pharmaceuticals Latest News for quick market reference.